Actively Recruiting
Impact of Breathing Exercises on Lung Function in Chronic Airway Diseases
Led by Mansoura University Hospital · Updated on 2025-05-29
50
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the benefits of a pulmonary rehabilitation program using breathing exercises for people with chronic airway diseases, including COPD and asthma. The study focuses on improving functional capacity measured by the six-minute walking distance test, reducing breathlessness using the Medical Research Council dyspnea scale, and enhancing lung function and arterial blood gases. It highlights the importance of breathing techniques to improve respiratory muscle efficiency and ventilation, which can help manage symptoms and improve quality of life. Participants are randomly assigned to one of two groups: one group receives usual medication treatment for chronic airway diseases without breathing exercises, while the other group receives medication combined with breathing exercises such as diaphragmatic breathing, pursed lip breathing, and use of an incentive spirometer. The study measures lung function outcomes like forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) over a 6-month period. During the study, participants undergo regular assessments including lung function tests and walking distance evaluations to track improvements. Researchers monitor symptoms and breathing capacity to understand the impact of the breathing exercises. The study includes adults aged 18 and older who have clinically stable COPD or asthma and have not previously participated in exercise training. The total study duration and follow-up details correspond to the 6-month outcome measurement period.
CONDITIONS
Brief Title
Breathing Exercises on Lung Function
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with COPD confirmed by post-bronchodilator FEV1 < 80% predicted and FEV1/FVC < 0.70
- COPD patients ranging from mild to severe according to GOLD stages I-IV
- Asthmatic patients treated medically for at least 6 months and clinically stable with no recent exacerbations or medication changes
- No prior participation in exercise training programs
- Optimized medical therapy according to GOLD and Global Initiative for Asthma (GINA) guidelines
- Clinically stable COPD and asthma patients without recent respiratory infections
- All patients are ex-smokers
You will not qualify if you...
- Age under 18 years
- Pregnancy
- Current smokers
- Patients unable to exercise or understand questionnaires
- Multiple co-morbidities like cardiovascular diseases or active cancer
- Neuromuscular diseases such as Myasthenia gravis or kypho-scoliosis
- Diaphragmatic paralysis with abnormal diaphragm movement
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants receive breathing exercises including diaphragmatic breathing, pursed lip breathing, and incentive spirometry alongside their regular medication for chronic airway diseases.
Weekly visits for breathing exercises and assessments
Trial Site Locations
Total: 1 location
1
Mohamed AbdElmoniem
Al Mansurah, Egypt, 35516
Actively Recruiting
Research Team
M
Mohamed AbdElmoniem
M
Mohamed Ahmed Ibrahim
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here